← Open Payments lookup

SUMMER FOUNTAIN: Open Payments

NPI 1922875327 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,817 in 75 payments from 27 companies in 2025. Trend: 2023 $128 · 2024 $3,104 · 2025 $1,817

Food & beverage: $1,817
CompanyPaymentsAmount
SK Life Science, Inc.9$278
UCB, Inc.9$235
Novartis Pharmaceuticals Corporation6$126
ACADIA Pharmaceuticals Inc5$125
JAZZ PHARMACEUTICALS INC.5$104
Alnylam Pharmaceuticals Inc.3$86
Janssen Biotech, Inc.4$85
Takeda Pharmaceuticals U.S.A., Inc.3$79
GENZYME CORPORATION2$65
Merz Pharmaceuticals, LLC2$62

Products named: Zilbrysq, KESIMPTA, EPIDIOLEX, NUPLAZID, AMVUTTRA, HYQVIA, Briviact, Xeomin.

Industry payments across AL — which companies pay providers there.